MULTIPLE SCLEROSIS (MS) SECONDARY PROGRESSIVE
Clinical trials for MULTIPLE SCLEROSIS (MS) SECONDARY PROGRESSIVE explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS (MS) SECONDARY PROGRESSIVE trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS (MS) SECONDARY PROGRESSIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAR t therapy takes on tough multiple sclerosis cases
Disease control Not yet recruitingThis early study tests a new treatment called S103 (BCMA-CAR T cells) in 9 adults with progressive or refractory multiple sclerosis (MS). The main goal is to check safety and find the right dose. The treatment uses specially engineered cells to target and attack certain immune ce…
Matched conditions: MULTIPLE SCLEROSIS (MS) SECONDARY PROGRESSIVE
Phase: PHASE1 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated May 17, 2026 06:52 UTC
-
New MS drug trial uses powerful 7T MRI to see inside the brain
Disease control Not yet recruitingThis study tests an experimental drug called remibrutinib in 20 people with relapsing or progressive multiple sclerosis (MS). Participants take the drug twice daily for 2 years and undergo ultra high-field 7T MRI scans to measure brain changes. The goal is to see if the drug can …
Matched conditions: MULTIPLE SCLEROSIS (MS) SECONDARY PROGRESSIVE
Phase: PHASE2 • Sponsor: Moein Amin • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Can clearing old cells help MS patients think and move better?
Symptom relief Not yet recruitingThis early-stage study tests whether a combination of two drugs, dasatinib and quercetin, can safely improve physical and mental function in adults aged 50-85 with secondary progressive multiple sclerosis (MS). Participants take the drugs every two weeks for three months. The goa…
Matched conditions: MULTIPLE SCLEROSIS (MS) SECONDARY PROGRESSIVE
Phase: PHASE1 • Sponsor: Ohio State University • Aim: Symptom relief
Last updated May 12, 2026 13:41 UTC